Outdoor ambient air pollution and neurodegenerative diseases: the neuroinflammation hypothesis
RL Jayaraj, EA Rodriguez, Y Wang… - Current environmental …, 2017 - Springer
Abstract Purpose of Review Accumulating research indicates that ambient outdoor air
pollution impacts the brain and may affect neurodegenerative diseases, yet the potential …
pollution impacts the brain and may affect neurodegenerative diseases, yet the potential …
Microglia: Multiple roles in surveillance, circuit shaping, and response to injury
EE Benarroch - Neurology, 2013 - AAN Enterprises
Microglial cells are the immune cells in the CNS and represent approximately 10% of the
total brain cell population. Their morphologic characterization by Pio del Rio-Hortega was …
total brain cell population. Their morphologic characterization by Pio del Rio-Hortega was …
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
D Brites, AR Vaz - Frontiers in cellular neuroscience, 2014 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is the most common and most aggressive form of adult
motor neuron (MN) degeneration. The cause of the disease is still unknown, but some …
motor neuron (MN) degeneration. The cause of the disease is still unknown, but some …
Dopaminergic regulation of innate immunity: a review
M Pinoli, F Marino, M Cosentino - Journal of neuroimmune pharmacology, 2017 - Springer
Dopamine (DA) is a neurotransmitter in the central nervous system as well as in peripheral
tissues. Emerging evidence however points to DA also as a key transmitter between the …
tissues. Emerging evidence however points to DA also as a key transmitter between the …
A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models
Astrocyte responses to neuronal injury may be beneficial or detrimental to neuronal
recovery, but the mechanisms that determine these different responses are poorly …
recovery, but the mechanisms that determine these different responses are poorly …
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
M Calafatti, G Cocozza, C Limatola… - Frontiers in …, 2023 - frontiersin.org
In recent years, biomedical research efforts aimed to unravel the mechanisms involved in
motor neuron death that occurs in amyotrophic lateral sclerosis (ALS). While the main …
motor neuron death that occurs in amyotrophic lateral sclerosis (ALS). While the main …
The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis
S Apolloni, C Parisi, MG Pesaresi, S Rossi… - The Journal of …, 2013 - journals.aai.org
Inflammation and oxidative stress are thought to play determinant roles in the pathogenesis
of amyotrophic lateral sclerosis (ALS). Degenerating motor neurons produce signals that …
of amyotrophic lateral sclerosis (ALS). Degenerating motor neurons produce signals that …
Neuroimmune and inflammatory signals in complex disorders of the central nervous system
AC Liberman, E Trias, L da Silva Chagas… - …, 2019 - karger.com
An extensive microglial-astrocyte-monocyte-neuronal cross talk seems to be crucial for
normal brain function, development, and recovery. However, under certain conditions …
normal brain function, development, and recovery. However, under certain conditions …
[HTML][HTML] Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson's disease
K Carmichael, B Sullivan, E Lopez… - Ageing and …, 2021 - ncbi.nlm.nih.gov
Abstract Parkinson's disease (PD), the most common degenerative movement disorder, is
clinically manifested with various motor and non-motor symptoms. Degeneration of midbrain …
clinically manifested with various motor and non-motor symptoms. Degeneration of midbrain …
NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study
RG Miller, R Zhang, G Block, J Katz… - … Lateral Sclerosis and …, 2014 - Taylor & Francis
This is a phase I, placebo-controlled, single ascending dose safety and tolerability study of
NP001 in patients with ALS. NP001 is a novel regulator of inflammatory macrophages and …
NP001 in patients with ALS. NP001 is a novel regulator of inflammatory macrophages and …